New, Simple Test Detects Rare Fatal Genetic Heart Condition
McMaster University
The new test will allow clinicians to identify individuals at risk of a life-threatening genetic heart arrhythmia
Heart Disease
New Drug Slows Rare, Debilitating Genetic Disease in Trials
National Institutes of Health
The NIH-supported clinical trial could lead to the first effective treatment for ACDC disease
Genetic Factors Linked to Atrial Fibrillation Could Drive CVDs
Elsevier
The paper analyzes current understanding of genetics in atrial fibrillation and recommends screening for genetic heart disease in early-onset cases
Metabolic Syndrome May Exacerbate Cervical Cancer Risk
York University
The survey findings reveal that women with metabolic syndrome have a 65 percent higher heart disease risk
Current Tools Underestimate CVD Risk in People with HIV
National Institutes of Health
Trial reveals the need for more accurate screening in Black people and cisgender women
New Biomarker-Based Model Predicts Imminent Risk of Heart Attack
Swathi Kodaikal, MSc
Some 48 proteins, 43 metabolites, age, sex, and systolic blood pressure were associated with the risk of first heart attack
Blood Biomarkers in Patients with Arthritis Predict CVD Risk
Mass General Brigham
The six blood biomarkers improved predictions about arterial inflammation—an indicator of cardiovascular risk
World-First Human Trial Offers New Type 1 Diabetes Treatment
St Vincent’s Institute of Medical Research
A commonly prescribed rheumatoid arthritis drug may suppress the progression of type 1 diabetes
SARS-CoV-2 Can Infect Arteries and Worsen Plaque Inflammation
National Institutes of Health
Latest study explores the link between COVID-19 infection and increased risk of cardiovascular disease and stroke
IL-1 Receptor Blocker Doesn’t Reduce Myocarditis Complications
European Society of Cardiology
Anakinra treatment didn’t show a significant spike in the number of days free of myocarditis in the largest randomized controlled trial